VERTEX PHARMACEUTICALS INC / MA - 8-K Filing

Vertex Pharmaceuticals appointed Daniel Brennan to its board of directors on October 20, 2026. (Items: 5.02 Departure of Directors of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of)

SEC EDGAR ·

Tickers: $VRTX

Read the full article at SEC EDGAR

More Regulatory news